Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy

Bone Marrow Transplant. 2022 Oct;57(10):1597-1599. doi: 10.1038/s41409-022-01757-9. Epub 2022 Jul 9.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Myeloablative Agonists
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / therapy
  • Transplantation Conditioning
  • Vidarabine / analogs & derivatives
  • Whole-Body Irradiation

Substances

  • Myeloablative Agonists
  • Vidarabine
  • fludarabine